ψ-Bufarenogin, a lead compound of anti-cancer drug

被引:4
|
作者
Ding, Jin [1 ]
Wang, Hongyang [1 ]
机构
[1] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Natl Ctr Liver Canc, Shanghai, Peoples R China
关键词
HEPATOCELLULAR-CARCINOMA;
D O I
10.1080/15384101.2015.1071139
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:2719 / 2720
页数:2
相关论文
共 50 条
  • [41] Indian anti-cancer drug trials halted
    Sharma, DC
    LANCET, 1999, 353 (9154): : 735 - 735
  • [42] Cannabidiol (CBD) as a Promising Anti-Cancer Drug
    Seltzer, Emily S.
    Watters, Andrea K.
    MacKenzie, Danny
    Granat, Lauren M.
    Zhang, Dong
    CANCERS, 2020, 12 (11) : 1 - 26
  • [43] Anti-Cancer Drug Screening with Microfluidic Technology
    Monjezi, Mojdeh
    Rismanian, Milad
    Jamaati, Hamidreza
    Kashaninejad, Navid
    APPLIED SCIENCES-BASEL, 2021, 11 (20):
  • [44] Bioinformatics Approaches for Anti-cancer Drug Discovery
    Li, Kening
    Du, Yuxin
    Li, Lu
    Wei, Dong-Qing
    CURRENT DRUG TARGETS, 2020, 21 (01) : 3 - 17
  • [45] Exosomes as Drug Carriers in Anti-Cancer Therapy
    Chen, Lan
    Wang, Li
    Zhu, Lingling
    Xu, Zihan
    Liu, Yanyang
    Li, Zhixi
    Zhou, Jin
    Luo, Feng
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [46] ROLE OF HEMOPERFUSION IN ANTI-CANCER DRUG REMOVAL
    WINCHESTER, J
    RAHMAN, A
    BREGMAN, H
    MORTENSEN, LM
    GELFAND, MC
    SCHEIN, PS
    SCHREINER, GE
    ARTIFICIAL ORGANS, 1979, 3 (04) : 400 - 400
  • [47] FIRMS BATTLE OVER ANTI-CANCER DRUG
    SUN, M
    SCIENCE, 1983, 222 (4620) : 145 - 145
  • [48] Epigenetic reprogramming in anti-cancer drug resistance
    Tan, Jing
    CANCER SCIENCE, 2024, 115 : 402 - 402
  • [49] Recent Developments in Anti-Cancer Drug Research
    Faisca Phillips, Ana Maria
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (41) : 7282 - 7284
  • [50] Emergencies under drug anti-cancer treatment
    Alig, Annabel
    von Bergwelt, Michael
    Giessen-Jung, Clemens
    ONKOLOGE, 2020, 26 (02): : 120 - 128